RecruitingNCT05746221

INflammation and Small Vessel Disease Study

Sponsor

University of Cambridge

Enrollment

200 participants

Start Date

Aug 10, 2022

Study Type

OBSERVATIONAL

Conditions

Stroke Inflammation Cerebral Small Vessel Diseases

Summary

A prospective observational cohort study in patients with cerebral small vessel disease deterring whether changes in systemic inflammation predict brain white matter damage measured using MRI and cognitive decline. This is a study funded by a joint BHF-Dutch Heart Foundation research grant and will be conducted in both Cambridge UK and Nijmegen Netherlands with 100 of the 200 total participants recruited at each site, and data from both sites analysed together.

Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cerebral small vessel diseases, inflammation, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 40 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.